^
Association details:
Biomarker:WDR5 overexpression
Cancer:Bladder Cancer
Drug:OICR-9429 (WDR5 inhibitor)
Direction:Resistant
Evidence:
Evidence Level:
Resistant: D – Preclinical
Title:

Targeting WD repeat domain 5 enhances chemosensitivity and inhibits proliferation and programmed death-ligand 1 expression in bladder cancer

Published date:
06/21/2021
Excerpt:
First, we found that WDR5 expression was upregulated in BCa and was associated...High WDR5 expression level was also correlated with shorter overall survival (OS) in Bca.
DOI:
10.1186/s13046-021-01989-5